Who owns ITERUM THERAPEUTICS PLC?
- Ticker: ITRM
- CUSIP Number: g6333l200
Tip: Access positions for across all investors
Analyze quarterly positions in Iterum Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Iterum Therapeutics stock
Who bought or sold ITERUM THERAPEUTICS PLC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Point72 Asset Management | 434k | $668k | 100% | Mar 2024 |
|
Apollon Financial | 225k | $346k | 100% | Mar 2024 |
|
Millennium Management | 28k | $43k | 100% | Mar 2024 |
|
Vontobel Holding | 15k | $23k | 100% | Mar 2024 |
|
UBS Group | 12k | $19k | 143% | Mar 2024 |
|
Morgan Stanley | 5.5k | $8.4k | -61% | Mar 2024 |
|
Wells Fargo & Company | 1.3k | $2.0k | 0% | Mar 2024 |
|
Tower Research Capital | 468.00 | $721.000800 | 2027% | Mar 2024 |
|
Royal Bank of Canada | 100.00 | $0 | -99% | Mar 2024 |
|
Larson Financial Group | 13.00 | $20.000500 | 0% | Mar 2024 |
|
Advisor Group Holdings | 12.00 | $18.000000 | 0% | Mar 2024 |
|
National Bank Of Canada /fi/ | 2.00 | $4.000000 | 0% | Dec 2023 |
|
Who sold out of Iterum Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Susquehanna International | Sep 2023 | 48k | $40k |
Goss Wealth Management | Sep 2023 | 100.00 | $80.000000 |